Raymond James Financial Services Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$64.2K Buy
15,584
+254
+2% +$1.05K ﹤0.01% 3326
2024
Q2
$100K Hold
15,330
﹤0.01% 3225
2024
Q1
$134K Hold
15,330
﹤0.01% 3179
2023
Q4
$175K Buy
15,330
+1,483
+11% +$17K ﹤0.01% 3020
2023
Q3
$133K Buy
13,847
+76
+0.6% +$732 ﹤0.01% 3015
2023
Q2
$147K Buy
13,771
+46
+0.3% +$489 ﹤0.01% 2995
2023
Q1
$144K Sell
13,725
-92
-0.7% -$968 ﹤0.01% 2988
2022
Q4
$171K Buy
13,817
+72
+0.5% +$892 ﹤0.01% 2901
2022
Q3
$142K Sell
13,745
-303
-2% -$3.13K ﹤0.01% 2923
2022
Q2
$162K Buy
14,048
+2,000
+17% +$23.1K ﹤0.01% 2903
2022
Q1
$152K Buy
12,048
+85
+0.7% +$1.07K ﹤0.01% 3021
2021
Q4
$139K Buy
11,963
+417
+4% +$4.85K ﹤0.01% 3061
2021
Q3
$151K Hold
11,546
﹤0.01% 3043
2021
Q2
$149K Sell
11,546
-1,000
-8% -$12.9K ﹤0.01% 3074
2021
Q1
$140K Buy
12,546
+1,000
+9% +$11.2K ﹤0.01% 2986
2020
Q4
$132K Hold
11,546
﹤0.01% 2815
2020
Q3
$104K Buy
11,546
+150
+1% +$1.35K ﹤0.01% 2677
2020
Q2
$118K Hold
11,396
﹤0.01% 2599
2020
Q1
$115K Hold
11,396
﹤0.01% 2200
2019
Q4
$152K Hold
11,396
﹤0.01% 2634
2019
Q3
$98K Sell
11,396
-200
-2% -$1.72K ﹤0.01% 2638
2019
Q2
$127K Buy
+11,596
New +$127K ﹤0.01% 2641
2018
Q2
Sell
-13,711
Closed -$177K 2776
2018
Q1
$177K Hold
13,711
﹤0.01% 2287
2017
Q4
$172K Sell
13,711
-298
-2% -$3.74K ﹤0.01% 2296
2017
Q3
$185K Sell
14,009
-511
-4% -$6.75K ﹤0.01% 2304
2017
Q2
$230K Hold
14,520
﹤0.01% 2125
2017
Q1
$207K Buy
14,520
+1,072
+8% +$15.3K ﹤0.01% 2115
2016
Q4
$172K Buy
+13,448
New +$172K ﹤0.01% 2103